Strength
75 mg/1
Manufacturer
Lannett Company Inc.NDC
00527459313
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA212739On Market Since
5/15/2023
Pharmacological Classes
Neuraminidase Inhibitor
Neuraminidase Inhibitors
Related Drugs
Same classification
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
69097090443•Cipla USA Inc.
$0.1519
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
00093818064•Teva Pharmaceuticals USA Inc.
$0.1548
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
27241013909•Ajanta Pharma USA Inc.
$0.1548
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
47781038426•Alvogen Inc.
$0.1548
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
59651059760•Aurobindo Pharma Limited
$0.1548
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
64380087975•Strides Pharma Inc.
$0.1548
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
68180067801•Lupin Pharmaceuticals Inc.
$0.1548
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
69238127306•Amneal Pharmaceuticals NY LLC
$0.1548
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
76282073952•Exelan Pharmaceuticals Inc.
$0.1548
per ML
OSELTAMIVIR PHOS 30 MG CAPSULE
Generic
47781046813•Alvogen Inc.
$0.7839
per EA